JP2008545752A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545752A5 JP2008545752A5 JP2008514854A JP2008514854A JP2008545752A5 JP 2008545752 A5 JP2008545752 A5 JP 2008545752A5 JP 2008514854 A JP2008514854 A JP 2008514854A JP 2008514854 A JP2008514854 A JP 2008514854A JP 2008545752 A5 JP2008545752 A5 JP 2008545752A5
- Authority
- JP
- Japan
- Prior art keywords
- igf
- subject
- growth hormone
- growth
- protein according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68761705P | 2005-06-02 | 2005-06-02 | |
| PCT/US2006/021282 WO2006130769A2 (en) | 2005-06-02 | 2006-06-01 | Methods for treatment of growth disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014043298A Division JP2014129405A (ja) | 2005-06-02 | 2014-03-05 | 成長障害を処置するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008545752A JP2008545752A (ja) | 2008-12-18 |
| JP2008545752A5 true JP2008545752A5 (enExample) | 2009-08-20 |
Family
ID=37482318
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008514854A Pending JP2008545752A (ja) | 2005-06-02 | 2006-06-01 | 成長障害を処置するための方法 |
| JP2014043298A Pending JP2014129405A (ja) | 2005-06-02 | 2014-03-05 | 成長障害を処置するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014043298A Pending JP2014129405A (ja) | 2005-06-02 | 2014-03-05 | 成長障害を処置するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8158582B2 (enExample) |
| EP (1) | EP1901770B1 (enExample) |
| JP (2) | JP2008545752A (enExample) |
| ES (1) | ES2532089T3 (enExample) |
| WO (1) | WO2006130769A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7994127B2 (en) | 2007-06-08 | 2011-08-09 | Massachusetts Institute Of Technology | Treatment of rett syndrome |
| US8759299B2 (en) | 2009-07-22 | 2014-06-24 | Ipsen Pharma S.A.S. | Analogues of insulin-like growth factor-1 (IGF-1) having amino acid substitution at position 59 |
| EP2501367B1 (en) * | 2009-11-17 | 2015-01-21 | Ipsen Pharma S.A.S. | Formulation for HGH and RHIGF-1 combination |
| EP2863897B1 (en) * | 2012-06-21 | 2019-06-19 | Phosphorex Inc. | Nanoparticles of indirubin, derivatives thereof and methods of making and using same |
| BR112017012792A2 (pt) * | 2014-12-16 | 2018-01-02 | Puretein Bioscience Llc | métodos para aumentar a concentração de igf, para tratar uma condição, para melhorar ou manter a saúde e para melhorar uma característica |
| CA3073648A1 (en) * | 2017-08-24 | 2019-02-28 | Sanofi | Treatment of abnormal bone conditions in acid sphingomyelinase deficiency patients |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681814A (en) * | 1990-06-07 | 1997-10-28 | Genentech, Inc. | Formulated IGF-I Composition |
| US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
| US5374620A (en) * | 1990-06-07 | 1994-12-20 | Genentech, Inc. | Growth-promoting composition and its use |
| SE9002731D0 (sv) * | 1990-08-24 | 1990-08-24 | Kabivitrum Ab | Product comprising growth factor |
| TW267102B (enExample) * | 1992-03-13 | 1996-01-01 | Ciba Geigy | |
| IL106546A0 (en) | 1993-08-01 | 1993-12-08 | Zvi Rozenberg | Apparatus for a bicycle and a two wheel vehicle |
| US5646113A (en) * | 1994-04-07 | 1997-07-08 | Genentech, Inc. | Treatment of partial growth hormone insensitivity syndrome |
| US5824642A (en) * | 1994-04-07 | 1998-10-20 | Genentech, Inc. | Treatment of partial growth hormone insensitivity syndrome |
| US5741776A (en) * | 1995-05-22 | 1998-04-21 | Genentech, Inc. | Method of administration of IGF-I |
| DK2274978T3 (en) * | 2003-09-12 | 2015-06-15 | Ipsen Biopharmaceuticals Inc | Methods of treating an insulin-like growth factor-I (IGF-I) deficiency |
| EP2501367B1 (en) | 2009-11-17 | 2015-01-21 | Ipsen Pharma S.A.S. | Formulation for HGH and RHIGF-1 combination |
-
2006
- 2006-06-01 WO PCT/US2006/021282 patent/WO2006130769A2/en not_active Ceased
- 2006-06-01 JP JP2008514854A patent/JP2008545752A/ja active Pending
- 2006-06-01 EP EP06784529.7A patent/EP1901770B1/en not_active Not-in-force
- 2006-06-01 ES ES06784529.7T patent/ES2532089T3/es active Active
- 2006-06-01 US US11/915,978 patent/US8158582B2/en not_active Expired - Fee Related
-
2012
- 2012-03-12 US US13/417,983 patent/US8440616B2/en not_active Expired - Fee Related
-
2014
- 2014-03-05 JP JP2014043298A patent/JP2014129405A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Klepstad et al. | Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post‐herpetic neuralgia | |
| CA2653201A1 (en) | Compositions and uses of e3-gp19k for treating diabetes | |
| Lau et al. | Impact of current and emerging glucose-lowering drugs on body weight in type 2 diabetes | |
| PT762890E (pt) | Tratamento de diabetes | |
| Page-Wilson et al. | Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery | |
| JP2020536854A (ja) | 医学療法におけるセマグルチド | |
| Newshan et al. | Palliative care: pain and symptom management in persons with HIV/AIDS | |
| CN117355297A (zh) | 用于诱导褐色脂肪生成的方法和组合物 | |
| Zavatta et al. | Challenges in the management of chronic hypoparathyroidism | |
| RU2007101695A (ru) | Лекарственный препарат для лечения сахарного диабета на основе экзенатида и даларгина, применение и способ лечения | |
| JP2014129405A5 (enExample) | ||
| ES3062720T3 (en) | Sublingual epinephrine tablets | |
| BR112020018362A2 (pt) | Composição de glp-1 para tratar obesidade e controle de peso | |
| WO2024042518A1 (en) | Glp-1 receptor antagonist and methods of use thereof | |
| KR20090019896A (ko) | 도파민 또는 성장 호르몬 수용체 길항제와의 소마토스타틴-유사체의 조합물 | |
| JP2023510609A (ja) | Ｇｌｐ－１および／またはｇｌｐ－１類似体、ならびにインスリンおよび／またはインスリン類似体を含む併用療法 | |
| Cook | Growth hormone and estrogen: a clinician's approach | |
| US8614184B2 (en) | HCG formulations for achieving weight loss | |
| Aviv et al. | Patterns of local site reactions to subcutaneous glatiramer acetate treatment of multiple sclerosis: a clinicopathological study | |
| WO2006130769A3 (en) | Methods for treatment of growth disorders | |
| US20250352622A1 (en) | Glp-1 formulations and their uses | |
| US20040192781A1 (en) | Method of administration for metoclopramide and pharmaceutical formulation therefor | |
| US20250170091A1 (en) | Uses of selective androgen receptor modulator (sarm) compounds in chronic weight management | |
| EP2289555A1 (en) | Method of treating frailty | |
| US20240091318A1 (en) | Combination therapy comprising long acting glp-1/glucagon and npy2 receptor agonists |